The new law on organ donation, including an active donor registration system, will become effective in the summer of 2020!Last week it became clear that less than 50% of the 300.000 signatures needed for an advisory referendum on the legislative proposal were obtained. This means that there will be no further delay in introducing the new law.
After many years of struggle by many organizations and patient’s advocates this is fantastic news for all patients on the waiting list for an organ transplant. The current law is based on a so-called opt-in system. All adults can register their wish concerning organ donation after death: 25% have a positive registration, 10% have a negative registration, and 65% have no registration. In the latter cases, relatives of the deceased person are approached for consent to remove organs for donation. In practice, in about two thirds of these cases, the relatives do not give consent although it is known from polls that the majority of the Dutch population is in favour of organ donation. In the upcoming system, all people will again receive a registration form that includes options for positive and negative registration, as well as the option to leave the decision with the relatives. Those who do not return the registration form are supposed to be in favour of organ donation and they will twice receive a letter to clarify this consequence of not returning the registration form. This way, it is expected that there will be a rise in the number of positive registrations (either active or passive).
Even if the increase in the number of organ donations would turn out to be less than hoped for, I feel that the new law means a significant improvement for those who are faced with the sudden loss of a beloved one. The new system will force a decision on postmortal donation during life for each subject, which fits with the right of self-determination. Relatives of a deceased person are no longer asked to make a difficult decision on donation by someone else on a moment that is already dramatic enough.
While this is all good news, it is unlikely that the shortage of deceased organ donors will be solved completely in the near future. For patients in need for a kidney transplant, the gap is partly filled by donation from healthy living subjects. In the Radboudumc we celebrated the 50th anniversary of kidney transplantation earlier this year. In a historic overview of kidney transplantation in our center it was shown that the percentage of living donor transplantations has increased from about 10% to 70% over the last 25 years. While most donors are relatives or household members of the patients, about 10% of the donors have no relationship with the recipient who they even do not know. In my view, these altruistic donors are real heroes and deserve great admiration. During our anniversary symposium, one of the altruistic donors gave an inspiring talk about global achievements in reducing poverty and improving health, fueling an optimistic look at the future. With a growing number of people like him, for whom giving is more important than taking, we should be able to realize our ideals, including a transplant organ for anyone who needs it!
Luuk Hilbrands is member of theme Renal disorders.
Related news items
Evaluation of an AI system for detection of COVID-19 on Chest X-Ray images22 May 2020
In the journal Radiology RIHS researcher Keelin Murphy described how an artificial intelligence system (CAD4COVID-XRay) can identify characteristics of COVID-19 on chest x-rays with performance comparable to six independent radiologists.read more
Intra-articular corticosteroid injections increase the risk of requiring knee arthroplasty14 May 2020
In The Bone & Joint Journal, RIHS researcher Stan Wijn et al. showed that corticosteroid injections in the knee joint are associated with an increased risk of knee arthroplasty in patients with, or at risk of developing, symptomatic osteoarthritis of the knee.read more
Comenius Senior Fellowship for Jos Kole12 May 2020
Assistant professor in Healthcare Ethics, Jos Kole received a Comenius Senior Fellowship, a prestigious educational scholarship for his plan ‘Physicians with character’. Aim of this scholarship is to innovate the Master of Medicine program.read more
Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2)12 May 2020
In Lancet HIV RIHS researchers Angela Colbers and David Burger showed in an open-label, randomized controlled trial, that, when initiated in the 3rd trimester of pregnancy, achievement of VL <50cp/mL at delivery was more likely with dolutegravir-based therapy than with efavirenz-based regimens.read more
Early symptoms in Radboudumc healthcare workers who were tested for SARS-CoV-212 May 2020
In Eurosurveillance RIHS researcher Alma Tostmann and colleagues from the Radboudumc COVID-19 Team describe that general symptoms like fever, headache, general malaise and muscle ache were associated with a positive SARS-CoV-2 test. Respiratory symptoms however, were not predictive for SARS-CoV-2.read more
Tight controlled dose reduction of biologics in psoriasis patients7 May 2020
Published in JAMA Dermatology, RIHS researcher Selma Atalay and colleagues investigated in a randomized controlled trial a tight controlled dose reduction strategy of the biologics adalimumab, etanercept and ustekinumab in psoriasis patients.read more